Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Comment by Straniuson Nov 29, 2016 3:25pm
101 Views
Post# 25529405

RE:RE:RE:The stock will feel better after a good puke

RE:RE:RE:The stock will feel better after a good pukeJoe, I doubt the financials will be a negative catalyst for the share price. No one is expecting anything but a loss for the quarter ended Sept 30, 2016 since there is no revenue. You can safely ignore the earnings.

I agree that with cloreenbaconskin that the Q3/16 financials are hum ho and can largely be ignored. Focus on Q1/17 and thereafter.

The only things of interest on in the upcoming Sep 30, 2016 financials (yet to be released) are:
  1. how much cash was on the books as at Sep 30, 2016
  2. how big are the cash flows from operations is (you need to see this to estimate how long their cash balance will sustain this rate of spend)
  3. how much spending is going on down in the investing section (I would expect some spending on CAPEX to get the equipment installed and running) which will also be a draw on the cash balance if sustained
  4. what the share count is and how many warrants have been exercised (and how many remain as these will bring in incremental cash)
Remember, the financials and any management comments in the MD&A will be 2 months stale at this point, so they are not the most current indication of the financial status of the company.
Bullboard Posts